|
C11ORF30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83419999966183E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.598700E-03 |
| Normal-vs-Stage2 |
2.060000E-02 |
| Normal-vs-Stage3 |
2.48959997062315E-09 |
| Normal-vs-Stage4 |
1.45100000015219E-07 |
| Stage1-vs-Stage2 |
5.695200E-01 |
| Stage1-vs-Stage3 |
2.592500E-04 |
| Stage1-vs-Stage4 |
4.178500E-04 |
| Stage2-vs-Stage3 |
5.000200E-02 |
| Stage2-vs-Stage4 |
4.686000E-02 |
| Stage3-vs-Stage4 |
6.631600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.97159999945929E-07 |
| Normal-vs-AfricanAmerican |
8.08050000000726E-05 |
| Normal-vs-Asian |
9.551600E-01 |
| Caucasian-vs-AfricanAmerican |
2.395200E-01 |
| Caucasian-vs-Asian |
2.378200E-01 |
| AfricanAmerican-vs-Asian |
1.178420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.73940000472939E-08 |
| Normal-vs-Female |
3.230700E-04 |
| Male-vs-Female |
1.288010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.598200E-03 |
| Normal-vs-Age(41-60Yrs) |
9.785500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.13199999876679E-08 |
| Normal-vs-Age(81-100Yrs) |
1.973080E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.414800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.090600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.106000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.370500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.178200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.157800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.055800E-01 |
| Normal-vs-Grade 2 |
8.980100E-03 |
| Normal-vs-Grade 3 |
7.53380025031447E-10 |
| Normal-vs-Grade 4 |
4.06479999992548E-07 |
| Grade 1-vs-Grade 2 |
1.623200E-01 |
| Grade 1-vs-Grade 3 |
2.383100E-03 |
| Grade 1-vs-Grade 4 |
5.098400E-03 |
| Grade 2-vs-Grade 3 |
1.431280E-04 |
| Grade 2-vs-Grade 4 |
2.408100E-04 |
| Grade 3-vs-Grade 4 |
2.463000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.324400E-02 |
| Normal-vs-ccB subtype |
3.15660000027584E-07 |
| ccA subtype-vs-ccB subtype |
4.387500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14619999999921E-05 |
| Normal-vs-N1 |
3.880500E-03 |
| N0-vs-N1 |
1.016980E-01 |
|
|
